Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starti...
Eurofins CDMO Alphora Inc. is excited to announce an expansion of its API capacity and capabilities with the completion of its new API manufacturing faci...
Partnership with University of Montana drives the implementation of next-generation sequencing and forensic investigative genetic genealogy in identify...
Kisunla slowed cognitive and functional decline by up to 35% compared to placebo at 18 months in its pivotal Phase 3 study and reduced participants' risk...
Biogen Inc. has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology company foc...
Merck known as MSD outside of the United States and Canada, and Orion Corporation announced that notice has been provided of the mutual exercise of...
Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, today announced the launch of Celselect Slides 2....
AbbVie (NYSE: ABBV) announced the acquisition of Celsius Therapeutics, Inc. ("Celsius"), a privately held biotechnology company pioneering new...
The PPD clinical research business will nearly double its laboratory footprint in northern Kentucky, add more than 250 jobs The PPD clinical research bu...
Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, today launched four new anti-idiotypic anti...
Bora Pharmaceuticals Co., Ltd. announced that it has successfully entered into an agreement for Emergent BioSolutions’ sterile man...
AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for adults with moderately to severely ac...
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, unveiled a new clinical research laboratory build...
Partnership to accelerate development of lead product candidate, RO-104; a first-in-class tri-specific biologic for treating neovascular age-relat...
© 2025 Biopharma Boardroom. All Rights Reserved.
